Pregnancy-Related Complications in Patients With Fibromuscular Dysplasia: A Report From the European/International Fibromuscular Dysplasia Registry.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 17 4 2021
Statut: ppublish

Résumé

Current literature suggests a higher risk of pregnancy-related complications in patients with renal fibromuscular dysplasia (FMD). The aim of our study was to assess the nature and prevalence of pregnancy-related complications in patients subsequently diagnosed with FMD. A call for participation was sent to centers contributing to the European/International FMD Registry. Patients with at least 1 pregnancy were included. Data on pregnancy were collected through medical files and FMD characteristics through the European/International FMD Registry. Data from 534 pregnancies were obtained in 237 patients. Despite the fact that, in 96% of cases, FMD was not diagnosed before pregnancy, 40% of women (n=93) experienced pregnancy-related complications, mostly gestational hypertension (25%) and preterm birth (20%), while preeclampsia was reported in only 7.5%. Only 1 patient experienced arterial dissection and another patient an aneurysm rupture. When compared with patients without pregnancy-related complications, patients with complicated pregnancies were younger at FMD diagnosis (43 versus 51 years old;

Identifiants

pubmed: 32639884
doi: 10.1161/HYPERTENSIONAHA.120.15349
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

545-553

Investigateurs

Alexandre Persu (A)
Marco Pappaccogli (M)
Christophe Beauloye (C)
Patrick Chenu (P)
Jean-Philippe Lengelé (JP)
Frank Hammer (F)
Pierre Goffette (P)
Parla Astarci (P)
André Peeters (A)
Robert Verhelst (R)
Miikka Vikkula (M)
Patricia Van der Niepen (P)
Frank Van Tussenbroek (F)
Tine De Backer (T)
Sofie Gevaert (S)
Philippe Delmotte (P)
Wouter Vinck (W)
Daniel T Gordin (DT)
Ilkka Tikkanen (I)
Maarit Venermo (M)
George S Stergiou (GS)
Rosa Maria Bruno (RM)
Stefano Taddei (S)
Caterina Romanini (C)
Ilaria Petrucci (I)
Franco Rabbia (F)
Silvia Di Monaco (S)
Pietro Minuz (P)
Giancarlo Mansueto (G)
Sergio De Marchi (S)
Denise Marcon (D)
Bram Kroon (B)
Peter de Leeuw (P)
Andrzej Januszewicz (A)
Ewa Warchol-Celinska (E)
Aleksander Prejbisz (A)
Adam Witkowski (A)
Helena Witowicz (H)
Anna Aniszczuk-Hybiak (A)
Krzysztof Pieluszczak (K)
Magdalena Januszewicz (M)
Piotr Dobrowolski (P)
Esteban Poch (E)
Enrique Montagud-Marrahi (E)
Alicia Molina (A)
Elena Guillen (E)
Marta Burrel (M)
Hanen Chaker (H)
Faiçal Jarraya (F)
Anita Mäkelä (A)
Katarzyna Józwik-Plebanek (K)
Elżbieta Florczak (E)
Jacek Kądziela (J)

Auteurs

Marco Pappaccogli (M)

From the Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, Italy (M.P., S.D.M., F.R.).
Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).

Aleksander Prejbisz (A)

Department of Hypertension, National Institute of Cardiology, Warsaw, Poland (A. Prejbisz, A.A.-H., E.W.-C., A.J.).

Simina Ciurică (S)

Cardiology Department, Marie Curie Civil Hospital, CHU Charleroi, Lodelinsart, Belgium (S.C.).

Rosa Maria Bruno (RM)

Department of Clinical and Experimental Medicine University of Pisa, Italy (R.M.B., I.B.).
INSERM U970 Team 7, Paris Cardiovascular Research Centre - PARCC & Université de Paris, Paris, France (R.M.B.).

Anna Aniszczuk-Hybiak (A)

Department of Hypertension, National Institute of Cardiology, Warsaw, Poland (A. Prejbisz, A.A.-H., E.W.-C., A.J.).

Irene Bracalente (I)

Department of Clinical and Experimental Medicine University of Pisa, Italy (R.M.B., I.B.).

Tine De Backer (T)

Department of Cardiovascular Diseases, University Hospital Ghent, Belgium (T.D.B.).

Frédéric Debiève (F)

Obstetrics Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium (F.D.).

Philippe Delmotte (P)

Service de Cardiologie, CHU Ambroise Paré, Mons, Belgium (P.D.).

Silvia Di Monaco (S)

From the Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, Italy (M.P., S.D.M., F.R.).
Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).

Faiçal Jarraya (F)

Service de Néphrologie, CHU Hédi Chaker, Sfax, Tunisie/Unité de Recherche 12ES14 Pathologie rénale, Faculté de medicine, Sfax (F.J.).

Daniel Gordin (D)

Helsinki Hypertension Centre of Excellence (D.G., I.T.), University of Helsinki, Helsinki University Hospital, Finland.
Abdominal Center Nephrology (D.G., I.T.), University of Helsinki, Helsinki University Hospital, Finland.
Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Finland (D.G.).

Przemysław Kosiński (P)

Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland (P.K.).

Abraham A Kroon (AA)

Department of Internal Medicine, Division of General Internal Medicine, Section Vascular Medicine (A.A.K., P.d.L.), Maastricht University Medical Centre, Maastricht University, the Netherlands.
CARIM School for Cardiovascular Diseases (A.A.K., P.d.L.), Maastricht University Medical Centre, Maastricht University, the Netherlands.

Angela H E M Maas (AHEM)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands (A.H.E.M.M.).

Denise Marcon (D)

Department of Medicine, Unit of General Medicine and Hypertension, University of Verona, Italy (D.M., P.M.).

Pietro Minuz (P)

Department of Medicine, Unit of General Medicine and Hypertension, University of Verona, Italy (D.M., P.M.).

Enrique Montagud-Marrahi (E)

Service de Cardiologie, CHU Ambroise Paré, Mons, Belgium (P.D.).

Agnès Pasquet (A)

Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).

Esteban Poch (E)

Service de Cardiologie, CHU Ambroise Paré, Mons, Belgium (P.D.).

Franco Rabbia (F)

From the Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, Italy (M.P., S.D.M., F.R.).

George S Stergiou (GS)

Hypertension Center STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Greece (G.S.S.).

Ilkka Tikkanen (I)

Helsinki Hypertension Centre of Excellence (D.G., I.T.), University of Helsinki, Helsinki University Hospital, Finland.
Abdominal Center Nephrology (D.G., I.T.), University of Helsinki, Helsinki University Hospital, Finland.
Minerva Institute for Medical Research, Helsinki, Finland (I.T.).

Laurent Toubiana (L)

Sorbonne Université, Université Paris 13, Sorbonne Paris Cité, INSERM, UMR_S1142, LIMICS, IRSAN, France (L.T.).

Wouter Vinck (W)

Endocrinology Department, Saint-Augustinus Hospital, Wilrijk, Belgium (W.V.).

Ewa Warchoł-Celińska (E)

Department of Hypertension, National Institute of Cardiology, Warsaw, Poland (A. Prejbisz, A.A.-H., E.W.-C., A.J.).

Patricia Van der Niepen (P)

Department of Nephrology and Hypertension, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Belgium (P.V.d.N.).

Peter de Leeuw (P)

Department of Internal Medicine, Division of General Internal Medicine, Section Vascular Medicine (A.A.K., P.d.L.), Maastricht University Medical Centre, Maastricht University, the Netherlands.
CARIM School for Cardiovascular Diseases (A.A.K., P.d.L.), Maastricht University Medical Centre, Maastricht University, the Netherlands.

Andrzej Januszewicz (A)

Department of Hypertension, National Institute of Cardiology, Warsaw, Poland (A. Prejbisz, A.A.-H., E.W.-C., A.J.).

Alexandre Persu (A)

Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH